Pembrolizumab + pemetrexed + carboplatin

NCCP 00568 · Source reconciled; independent clinical, pharmacy and patient/PPI review pending

Practical treatment guide

Practical treatment planning

Agree the arrangements with your oncology team.

STEP 1

Treatment phases and appointments

Induction: all three medicines on Day 1 every 21 days for up to four cycles. Maintenance: carboplatin stops; pembrolizumab and pemetrexed may continue every 21 days while appropriate.

STEP 2

Checks after treatment

Folic acid continues throughout pemetrexed and for 21 days after its last dose. Vitamin B12 remains due every three cycles while pemetrexed continues. Immune-related symptoms can arise during or after treatment; maintain alert-card and urgent-contact education. Response imaging follows the consultant plan.

STEP 3

Access and practical support

IV treatment; no 46-hour home fluorouracil pump. Venous access choice is individual. Check B12 appointments, daily folate supply, steroid directions and the immunotherapy alert card across both phases.

Sources: NCCP 00568 v5 · official regimen. Source reconciled; independent clinical, pharmacy and patient/PPI review pending.